Outlook Therapeutics (OTLK) Leases: 2015-2020
Historic Leases for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $206,229.
- Outlook Therapeutics' Leases fell 97.42% to $206,229 in Q2 2020 from the same period last year, while for Jun 2020 it was $206,229, marking a year-over-year decrease of 97.42%. This contributed to the annual value of $3.0 million for FY2019, which is 62.28% down from last year.
- Latest data reveals that Outlook Therapeutics reported Leases of $206,229 as of Q2 2020, which was down 91.32% from $2.4 million recorded in Q1 2020.
- In the past 5 years, Outlook Therapeutics' Leases ranged from a high of $8.0 million in Q1 2019 and a low of $206,229 during Q2 2020.
- For the 3-year period, Outlook Therapeutics' Leases averaged around $5.5 million, with its median value being $7.5 million (2018).
- Its Leases has fluctuated over the past 5 years, first spiked by 124.36% in 2018, then slumped by 97.42% in 2020.
- Over the past 5 years, Outlook Therapeutics' Leases (Quarterly) stood at $3.7 million in 2016, then decreased by 4.00% to $3.5 million in 2017, then soared by 124.36% to $8.0 million in 2018, then tumbled by 69.20% to $2.5 million in 2019, then slumped by 97.42% to $206,229 in 2020.
- Its last three reported values are $206,229 in Q2 2020, $2.4 million for Q1 2020, and $2.5 million during Q4 2019.